Bluebird Bio Company Profile (NASDAQ:BLUE)

Analyst Ratings

Consensus Ratings for Bluebird Bio (NASDAQ:BLUE) (?)
Ratings Breakdown: 5 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $99.53 (101.85% upside)

Analysts' Ratings History for Bluebird Bio (NASDAQ:BLUE)
Show:
DateFirmActionRatingPrice TargetActions
7/14/2016Jefferies GroupReiterated RatingPositive$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016BTIG ResearchReiterated RatingBuy$72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016Cantor FitzgeraldInitiated CoverageHold$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Piper Jaffray Cos.Reiterated RatingBuy$117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Janney Montgomery ScottReiterated RatingBuy$91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WedbushReiterated RatingOutperform$117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Goldman Sachs Group Inc.Reiterated RatingNeutral$149.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Maxim GroupReiterated RatingBuy$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016Roth CapitalReiterated RatingNeutral$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015JPMorgan Chase & Co.DowngradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Bank of America Corp.DowngradeBuy -> Neutral$149.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Morgan StanleyDowngradeOverweight -> Equal Weight$143.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/16/2015Cowen and CompanyReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform$162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2015BMO Capital MarketsInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015SunTrust Banks Inc.Reiterated RatingBuy$205.00 -> $230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Bluebird Bio (NASDAQ:BLUE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/4/2016Q1($1.23)($1.52)$4.50 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q4($1.11)($1.29)$3.21 million$1.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.78)($1.57)$8.60 million$4.94 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115($0.61)($0.76)$6.20 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414($0.57)($0.67)$6.20 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.50)($0.61)$6.20 million$6.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.45)($0.06)$6.15 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.32)($0.44)$6.23 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014($0.31)($0.34)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3($0.25)($0.26)$5.59 million$6.39 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q213($0.35)($2.13)$4.85 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bluebird Bio (NASDAQ:BLUE)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 201610($1.38)($0.92)($1.21)
Q2 201610($1.56)($0.99)($1.36)
Q3 201610($1.61)($1.12)($1.41)
Q4 201610($1.67)($1.29)($1.48)
Q1 20171($1.68)($1.68)($1.68)
Q2 20171($1.75)($1.75)($1.75)
Q3 20171($1.83)($1.83)($1.83)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bluebird Bio (NASDAQ:BLUE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bluebird Bio (NASDAQ:BLUE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/20/2016Eric SullivanInsiderSell2,807$45.04$126,427.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2016David DavidsonInsiderSell1,000$45.08$45,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2016Philip D GregoryInsiderSell2,931$39.52$115,833.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016David DavidsonInsiderSell1,000$40.11$40,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016David DavidsonInsiderSell1,000$38.73$38,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016David DavidsonInsiderSell1,000$49.63$49,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016David DavidsonInsiderSell1,000$46.13$46,130.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016David DavidsoninsiderSell1,000$45.18$45,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016David DavidsoninsiderSell1,000$44.39$44,390.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015David DavidsoninsiderSell1,000$58.55$58,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Nick LeschlyCEOBuy9,682$51.75$501,043.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015David DavidsoninsiderSell2,000$70.99$141,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Jeffrey T. WalshCOOSell11,000$74.60$820,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015David DavidsoninsiderSell2,000$79.70$159,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/12/2015Jeffrey T. WalshCOOSell11,000$88.06$968,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2015Jason ColeSVPSell5,000$86.91$434,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Daniel LynchDirectorSell3,000$100.41$301,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015Daniel LynchDirectorSell1,500$140.06$210,090.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015David DavidsoninsiderSell2,000$129.98$259,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015Jeffrey T. WalshCOOSell11,000$130.02$1,430,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Jason ColeSVPSell2,000$136.56$273,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Daniel LynchDirectorSell7,000$132.75$929,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Nick LeschlyCEOSell125,000$135.24$16,905,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015James MandellDirectorSell1,500$125.96$188,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Eric SullivanInsiderSell1,126$163.36$183,943.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015David DavidsonInsiderSell2,000$165.96$331,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Jeffrey T WalshCOOSell11,000$158.63$1,744,930.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2015Jason ColeSVPSell5,000$158.19$790,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015David DavidsonInsiderSell2,000$183.34$366,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Jeffrey T WalshCOOSell11,000$179.70$1,976,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Mitchell H FinerInsiderSell15,000$190.25$2,853,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Mitchell H FinerInsiderSell15,000$126.03$1,890,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015David DavidsonInsiderSell2,000$130.18$260,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Jeffrey T WalshCOOSell21,000$126.21$2,650,410.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Eric SullivanInsiderSell2,998$117.81$353,194.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Jeffrey T WalshCOOSell10,500$110.06$1,155,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015David DavidsonInsiderSell4,000$94.84$379,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Jeffrey T WalshCOOSell10,500$103.57$1,087,485.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015David DavidsonInsiderSell4,000$90.01$360,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014John MaraganoreDirectorBuy2,352$85.00$199,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Jeffrey T WalshCOOSell43,500$78.06$3,395,610.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014David DavidsonInsiderSell15,000$46.10$691,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2014David DavidsonInsiderSell3,000$41.65$124,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Mitchell H FinerInsiderSell18,000$39.70$714,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Nick LeschlyCEOSell2,417$39.70$95,954.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014David DavidsonInsiderSell3,000$41.68$125,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Nick LeschlyCEOSell25,000$41.68$1,042,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Nick LeschlyCEOSell33,900$40.22$1,363,458.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2014Jeffrey T WalshCOOSell7,500$33.16$248,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2014Steven GillisDirectorSell115,000$35.25$4,053,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014Mitchell H FinerInsiderSell34,518$33.52$1,157,043.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2014Steven GillisDirectorSell57,435$35.43$2,034,922.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2014Steven GillisDirectorSell91,165$35.28$3,216,301.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014David DavidsonInsiderSell3,000$34.55$103,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Nick LeschlyCEOSell8,000$34.55$276,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Robert I TepperDirectorSell125,000$36.54$4,567,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Jeffrey T WalshCOOSell7,500$37.02$277,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014David DavidsonInsiderSell3,000$38.00$114,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Nick LeschlyCEOSell10,300$38.45$396,035.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Jeffrey T WalshCOOSell7,500$34.26$256,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014David DavidsonInsiderSell3,000$33.62$100,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Nick LeschlyCEOSell8,000$33.62$268,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014John MaraganoreDirectorBuy2,941$34.00$99,994.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Jeffrey T WalshCOOSell7,500$33.20$249,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2014Nick LeschlyCEOSell22,283$39.86$888,200.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014David DavidsonInsiderSell3,000$39.55$118,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Nick LeschlyCEOSell17,075$40.06$684,024.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Jeffrey T WalshCOOSell1,500$39.86$59,790.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Mitchell H FinerInsiderSell10,000$39.84$398,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Nick LeschlyCEOSell42,925$40.02$1,717,858.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Jeffrey T WalshCOOSell6,000$24.23$145,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Mitchell H FinerInsiderSell8,000$22.21$177,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Nick LeschlyCEOSell5,000$22.21$111,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Jeffrey WalshCOOSell1,500$20.03$30,045.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Jeffrey WalshCOOSell4,500$18.93$85,185.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014David DavidsonInsiderSell4,000$19.85$79,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Nick LeschlyCEOSell5,000$20.07$100,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2014Jeffrey WalshCOOSell6,000$21.29$127,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Linda BainVPSell2,500$25.11$62,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2014Robert TepperDirectorSell307,000$22.43$6,886,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Mitchell FinerInsiderSell10,000$23.52$235,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Robert TepperDirectorSell340,000$21.90$7,446,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Jeffrey WalshCOOSell6,000$21.98$131,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014David DavidsonInsiderSell15,000$20.88$313,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014Linda BainVPSell5,000$20.89$104,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bluebird Bio (NASDAQ:BLUE)
DateHeadline
07/23/16 07:08 AMEquity Roundup: Stock Performance Focus on bluebird bio, Inc. (NASDAQ:BLUE) - Press Telegraph
07/22/16 11:02 AMStocks inside Analysts Spotlight: Cigna Corporation (NYSE:CI) , bluebird bio, Inc. (NASDAQ:BLUE) - Street Updates
07/21/16 02:54 PMbluebird bio, Inc. (NASDAQ:BLUE): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 02:54 PMRecent Insider Trading Alert: bluebird bio Inc (NASDAQ:BLUE ... - Post Registrar
07/21/16 02:54 PMbluebird bio Inc. (BLUE) Jumps 6.91% on July 20 - Equities.com
07/21/16 02:54 PMAnalyst Recommendations Watch: bluebird bio, Inc. (NASDAQ:BLUE) - News Oracle
07/21/16 02:54 PMbluebird bio Inc Increases Again; Strong Momentum for Buyers - Consumer Eagle
07/20/16 10:55 AMOne Kendall Sq. sold
07/20/16 10:55 AMCelgene (CELG), Jounce Strike Immunotherapy Collaboration
07/19/16 02:54 PMbluebird bio : Presents megaTAL Genome Editing Data at American Society of Hematology (ASH) Workshop on Genome Editing
07/18/16 07:53 AMShare Performance Summary for: bluebird bio, Inc. (NASDAQ:BLUE) - Press Telegraph
07/18/16 07:53 AMAnalysts and Technical Update on Bluebird Bio Inc (NASDAQ:BLUE) - Street Report
07/18/16 07:30 AMbluebird bio Presents megaTAL Genome Editing Data at American Society of Hematology (ASH) Workshop on Genome Editing - [Business Wire] - bluebird bio, Inc. , a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced the presentation of pre-clinical data from its megaTAL genome editing platform at the ASH Workshop on Genome Editing, held July 14-15 in Washington, D.C.
07/17/16 07:33 AMLarge Inflow of Money Detected in bluebird bio - TheFounders Daily
07/17/16 07:33 AMStrong Sell Calls For bluebird bio, Inc. (NASDAQ:BLUE) At 0 - Investor Newswire
07/15/16 01:29 PMAmerican Society of Hematology Holds Foundational Workshop on Genome Editing
07/14/16 08:21 PMbluebird bio Inc Realized Volatility Hits Elevated Level - CML News
07/14/16 02:56 PMStocks Buzz: bluebird bio, Inc. (BLUE) Fairmount Santrol Holdings Inc. (FMSA) Sequenom Inc. (SQNM) - iStreetWire
07/13/16 08:18 PMBluebird Bio Incorporated (NASDAQ:BLUE) Shorted Shares Increased 6.67% After Market Selling - Consumer Eagle
07/13/16 02:53 PMbluebird bio, Inc. (NASDAQ:BLUE) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 02:53 PMNotable Stocks within Analysts Radar: Medtronic plc (NYSE:MDT) , bluebird bio, Inc. (NASDAQ:BLUE) - Street Updates
07/12/16 07:02 AMShares Moving Up Over the Past Quarter: bluebird bio, Inc. (NASDAQ:BLUE) - Engelwood Daily
07/12/16 07:02 AMActive Stocks: bluebird bio, Inc. (NASDAQ:BLUE), Encana (NYSE:ECA), Barrick Gold (NYSE:ABX), Amicus ... - KC Register
07/12/16 07:02 AMAnalysts Trends to Watch: bluebird bio, Inc. (NASDAQ:BLUE) , TESARO, Inc. (NASDAQ:TSRO) - Street Updates
07/11/16 07:44 AMWall Street Ratings and Target Price Views on bluebird bio, Inc. (NASDAQ:BLUE) - Telanagana Press
07/10/16 02:48 PMIs $164 Within Reach For bluebird bio, Inc. (NASDAQ:BLUE)? - Investor Newswire
07/10/16 02:48 PMIs $164 Within Reach For bluebird bio, Inc. (NASDAQ:BLUE)? - Investor Newswire
07/10/16 02:48 PMAre Analysts Bullish bluebird bio Inc (NASDAQ:BLUE) After Last Week? - Press Telegraph
07/08/16 07:59 PMHere's How Juno Therapeutics Inc (JUNO) Dragged down Kite Pharma Inc, Bluebird Bio Inc Stocks - Bidness ETC
07/08/16 11:01 AMWhy is Juno Therapeutics (JUNO) Stock Plunging 31% Today? -
07/08/16 10:54 AMJuno plunges after 3 patients die in trial of cancer therapy
07/08/16 10:54 AMJuno cancer study halted after patient deaths; shares slide 30%
07/08/16 10:54 AMJuno cancer study halted after patient deaths
07/07/16 08:09 PMbluebird bio, Inc. Stock Momentum at Critical Inflection Point - CML News
07/07/16 04:24 PMJuno tanks after hours -
07/07/16 02:54 PMbluebird bio Inc Draws Bullish Attention After Forming Bullish Descending Triangle - Press Telegraph
07/07/16 02:54 PMbluebird bio Inc. (BLUE) Jumps 7.5% on July 06 - Equities.com
07/06/16 02:54 PMCan bluebird bio, Inc. (NASDAQ:BLUE) Improve on the Earnings Front? - Engelwood Daily
07/06/16 02:54 PMBroker Outlook For Bluebird Bio, Inc. (NASDAQ:BLUE) - Fiscal Standard
07/06/16 07:43 AMStock Tracking Down This Month; Investor Alert on bluebird bio, Inc. (NASDAQ:BLUE) - Engelwood Daily
07/06/16 07:43 AMbluebird bio Inc. (BLUE) Jumps 5.45% on July 04 - Equities.com
07/05/16 11:00 AMbluebird bio, Inc. – Value Analysis (NASDAQ:BLUE) : July 5, 2016 -
07/04/16 02:49 PMBroker Outlook For The Week Ahead Bluebird Bio, Inc. (NASDAQ:BLUE) - Fiscal Standard
07/03/16 02:47 PMbluebird bio, Inc. (NASDAQ:BLUE) Expected to Reach Highs Of $164 - Investor Newswire
07/03/16 02:47 PMShare Performance Recap for: bluebird bio, Inc. (NASDAQ:BLUE) - Press Telegraph
07/02/16 10:33 AMbluebird bio Inc. (BLUE) Jumps 5.45% on July 01 - Equities.com
07/01/16 02:55 PMBrain Edema Pipeline Reviewed for Global Markets in H1 2016 Report
07/01/16 10:59 AMShort Term Price Target on bluebird bio (BLUE) - Trade Calls
07/01/16 10:59 AMStocks News Update: bluebird bio Inc (NASDAQ:BLUE), Store Capital Corp (NYSE:STOR), Superior Energy Services ... - iStreetWire
07/01/16 07:07 AMbluebird bio, Inc. breached its 50 day moving average in a Bullish Manner : BLUE-US : July 1, 2016 -

Social

About Bluebird Bio

Bluebird Bio logobluebird bio, Inc. is a biotechnology company. The Company is focused on developing transformative gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy. Its gene therapy clinical programs include LentiGlobin product candidate to treat transfusion-dependent B-thalassemia (TDT) and severe sickle cell disease (SCD), and Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD), a rare hereditary neurological disorder. Its oncology programs are built using lentiviral gene delivery and T cell engineering, with a focus on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. Its oncology program, bb2121, is a CAR T cell product candidate targeting B-cell maturation antigen, or BCMA, in multiple myeloma. It also offers discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BLUE
  • CUSIP:
Key Metrics:
  • Previous Close: $48.88
  • 50 Day Moving Average: $44.33
  • 200 Day Moving Average: $45.59
  • P/E Ratio: N/A
  • P/E Growth: -0.04
  • Market Cap: $1.82B
  • Beta: 1.7
  • Current Year EPS Consensus Estimate: $-5.95 EPS
  • Next Year EPS Consensus Estimate: $-6.14 EPS
Additional Links:
Bluebird Bio (NASDAQ:BLUE) Chart for Saturday, July, 23, 2016